Overview

Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis

Status:
Completed
Trial end date:
2002-01-27
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and efficacy of FK463 in the treatment of patients with confirmed candidemia or invasive candidiasis.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Micafungin